Downregulation of GSTπ expression by tryptanthrin contributing to sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-terminal kinase-mediated apoptosis

Anti-Cancer Drugs - Tập 20 Số 5 - Trang 382-388 - 2009
Sung-Tsai Yu1, Tzer-Ming Chen, Ji‐Wang Chern, Shih-Yun Tseng, Yen‐Hui Chen2
1Graduate Institute of Pharmaceutical Sciences, College of Medicine, National Taiwan University, Taipei, Taiwan.
2to Yen-Hui Chen, PhD, Graduate Institute of Pharmaceutical Sciences, College of Medicine, National Taiwan University, No. 1, Section 1, Jen-Ai Road, Taipei 10051, Taiwan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Krishna, 2000, Multidrug resistance (MDR) in cancer: mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs, Eur J Pharm Sci, 11, 265, 10.1016/S0928-0987(00)00114-7

Gottesman, 2006, The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research, FEBS Letters, 580, 998, 10.1016/j.febslet.2005.12.060

Luqmani, 2005, Mechanisms of drug resistance in cancer chemotherapy, Med Princ Pract, 14, 35, 10.1159/000086183

Kuzmich, 1991, Detoxification mechanisms and tumor cell resistance to anticancer drugs, Med Res Rev, 11, 185, 10.1002/j.1098-1128.1991.tb00003.x

Batist, 1986, Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells, J Biol Chem, 261, 15544, 10.1016/S0021-9258(18)66748-1

Lai, 1991, Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines, Int J Cancer, 49, 688, 10.1002/ijc.2910490511

Adler, 1999, Regulation of JNK signaling by GSTp, EMBO J, 18, 1321, 10.1093/emboj/18.5.1321

Wang, 2001, Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus, J Biol Chem, 276, 20999, 10.1074/jbc.M101355200

Asakura, 2004, Chemotherapeutic agents that induce mitochondrial apoptosis, Curr Cancer Drug Targets, 4, 577, 10.2174/1568009043332772

Asakura, 2007, Conformational change in the active center region of GST P1-1, due to binding of a synthetic conjugate of DXR with GSH, enhanced JNK-mediated apoptosis, Apoptosis, 12, 1269, 10.1007/s10495-007-0053-0

Ploemen, 1990, Inhibition of rat and human glutathione S-transferase isoenzymes by ethacrynic acid and its glutathione conjugate, Biochem Pharmacol, 40, 1631, 10.1016/0006-2952(90)90465-W

Flatgaard, 1993, Isozyme specificity of novel glutathione-S-transferase inhibitors, Cancer Chemother Pharmacol, 33, 63, 10.1007/BF00686025

Drake, 1987, Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme, J Biol Chem, 262, 16739, 10.1016/S0021-9258(18)49317-9

Kamath, 1992, Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone, Biochem Pharmacol, 44, 937, 10.1016/0006-2952(92)90126-4

Danz, 2001, Identification and isolation of the cyclooxygenase-2 inhibitory principle in Isatis tinctoria, Planta Med, 67, 411, 10.1055/s-2001-15805

Kataoka, 2001, Antibacterial action of tryptanthrin and kaempferol, isolated from the indigo plant (Polygonum tinctorium Lour.), against Helicobacter pylori-infected Mongolian gerbils, J Gastroenterol, 36, 5, 10.1007/s005350170147

Koya-Miyata, 2001, Prevention of azoxymethane-induced intestinal tumors by a crude ethyl acetate-extract and tryptanthrin extracted from Polygonum tinctorium Lour, Anticancer Res, 21, 3295

Yu, 2007, Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells, Biochem Biophys Res Commun, 358, 79, 10.1016/j.bbrc.2007.04.107

Beck, 1994, High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias, Cancer Lett, 86, 135, 10.1016/0304-3835(94)90190-2

Lacave, 1998, Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas, Br J Cancer, 77, 694, 10.1038/bjc.1998.115

Habig, 1974, Glutathione S-transferases. The first enzymatic step in mercapturic acid formation, J Biol Chem, 249, 7130, 10.1016/S0021-9258(19)42083-8

Townsend, 2003, The role of glutathione-S-transferase in anti-cancer drug resistance, Oncogene, 22, 7369, 10.1038/sj.onc.1206940

Fojo, 2003, Strategies for reversing drug resistance, Oncogene, 22, 7512, 10.1038/sj.onc.1206951

Tew, 1988, Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines, Cancer Res, 48, 3622

Clapper, 1990, Sensitization of human colon tumor xenografts to L-phenylalanine mustard using ethacrynic acid, J Cell Pharmacol, 1, 71

Asakura, 2001, Suppression of GST-P by treatment with glutathione-doxorubicin conjugate induces potent apoptosis in rat hepatoma cells, Int J Cancer, 94, 171, 10.1002/ijc.1465

Narang, 2007, Sulfasalazine-induced reduction of glutathione levels in breast cancer cells: enhancement of growth-inhibitory activity of doxorubicin, Chemotherapy, 53, 210, 10.1159/000100812

Takada, 2008, c-Jun-NH2-terminal kinase potentiates apoptotic cell death in response to carboplatin in B lymphoma cells, Cancer Chemother Pharmacol, 62, 569, 10.1007/s00280-007-0638-x

Kim, 2003, JNK/SAPK mediates doxorubicin-induced differentiation and apoptosis in MCF-7 breast cancer cells, Breast Cancer Res Treat, 79, 321, 10.1023/A:1024043302583

Bugg, 1991, Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide, Proc Natl Acad Sci U S A, 88, 7654, 10.1073/pnas.88.17.7654